跳至主要内容
临床试验/CTRI/2013/10/004088
CTRI/2013/10/004088招募中未知

Applicability of the International Cooperative Ataxia Rating Scale (ICARS) in younger patients and development of global rating instruments for patients with Ataxia Telangiectasia (AT)

Erydel SPA0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
Erydel SPA
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Patients aged 6-18 years with diagnosed with ataxia, preferably AT will be included. The diagnosis of AT will be made based on the criteria: typical clinical picture plus one of the following: 1. a proven mutation in the ATM gene 2. Deficient ATM protein proven by Western blotting 3. Elevated α-fetoprotein, cerebellar atrophy on MRI and immune deficiency/ chromosomal breakage/ T- cell lymphoreticular malignancy.
  • 2.Children aged 6-18 years with suspected AT (fulfilling partially the above criteria will be included)
  • 3.Children aged 6-18 years with AT like disease, with or without proven mutation in the MRE11 gene will be included
  • 4.Children aged 6-18 years of age with ataxia of other known or unknown etiologies might be included, but their total number should not exceed 20% of the cohort in each site

排除标准

  • 未提供

研究者

发起方
Erydel SPA

相似试验